Biotech

News SRTD biotech receives seed financing The seed funding makes it possible to further develop a platform for targeted RNA therapies. The goal: better cancer therapies without side effects.
News BioNTech acquires Biotheus for 800 million euros The acquisition of Biotheus gives BioNTech worldwide rights to BNT327/PM8002 and further advances research into innovative combination cancer therapies.
News SynOx Therapeutics increases capital to USD 92 million in Series B financing Gilde Healthcare leads Series B extension and supports Phase 3 TANGENT study for emactuzumab, a promising CSF-1R-targeted therapy for tenosynovial giant cell tumor
News Infinite Roots receives 2.6 million euros in funding Infinite Roots transforms whey waste into valuable resources. The Hamburg-based biotech company aims to use whey as a substrate for mycelium production and create new, environmentally friendly products.
News Reliant AI launches with seed funding of 11.3 million dollars The startup is launching Reliant Tabular, an AI workbench designed to radically accelerate data processing in the biopharma industry.
News Infinite Roots receives 58 million US dollars Biotech company Infinite Roots receives financial injection from industry leaders to further develop mushroom mycelium technologies.
News X2.0 launches the 3rd Open Call for HealthTech and BioTech start-ups X2.0 announces the ten AgriTech start-ups selected for the current funding program and launches the 3rd Open Call for HealthTech and BioTech. Sustainable innovations are supported. Application deadline until Sept. 5.
News Financing boom for German biotechs The industry was able to collect around 2.3 billion euros last year. That is almost a record.
Interviews Startup of the month Prevention instead of just treating the symptoms Intestinal flora is a term that many people would prefer never to talk about. Yet it has a massive impact on physical health. The founding team of Biomes wants to change this - and revolutionize the healthcare system...
News 64 million euros for Cardior The biotech company from Hanover is delighted with an oversubscribed Series B financing round. The start-up now wants to press ahead with the development of its heart drug.

FYI: English edition available

Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?

Go to English edition

FYI: Deutsche Edition verfügbar

Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?

Deutsche Edition öffnen